| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/01/2023 | 152.53% | BTIG | → $5 | Initiates Coverage On | → Buy |
| 06/30/2023 | — | TD Cowen | Initiates Coverage On | → Market Perform | |
| 01/04/2022 | — | William Blair | Initiates Coverage On | → Outperform |
What is the target price for P3 Health Partners (PIII)?
The latest price target for P3 Health Partners (NASDAQ: PIII) was reported by BTIG on September 1, 2023. The analyst firm set a price target for $5.00 expecting PIII to rise to within 12 months (a possible 152.53% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for P3 Health Partners (PIII)?
The latest analyst rating for P3 Health Partners (NASDAQ: PIII) was provided by BTIG, and P3 Health Partners initiated their buy rating.
When is the next analyst rating going to be posted or updated for P3 Health Partners (PIII)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of P3 Health Partners, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for P3 Health Partners was filed on September 1, 2023 so you should expect the next rating to be made available sometime around September 1, 2024.
Is the Analyst Rating P3 Health Partners (PIII) correct?
While ratings are subjective and will change, the latest P3 Health Partners (PIII) rating was a initiated with a price target of $0.00 to $5.00. The current price P3 Health Partners (PIII) is trading at is $1.98, which is within the analyst's predicted range.